PANBIO™ COVID-19 Ag Rapid Test Device Nasal - Box/25
PANBIO™ COVID-19 Ag Rapid Test Device is a patient-friendly nasal self-collected swab option minimizes health worker exposure.
Abbott’s Pan bio™ COVID-19 Ag Rapid Test Device is approved for inclusion in the Australian Register of Therapeutic Goods (ARTG) for nasal or nasopharyngeal swab specimens and is an in vitro diagnostic rapid test for the qualitative detection of SARS-CoV-2 antigen (Ag) from individuals who meet COVID-19 clinical and/or epidemiological criteria.
The test is for professional use only and is intended to be used as an aid in the diagnosis of SARS-CoV-2 infection.
Testing Use Cases:
- Screening asymptomatic individuals
- Individuals presenting with symptoms in the last 7 days
- Individuals suspected of exposure to COVID-19
Features & Benefits:
Mass screening of populations including asymptomatic individuals can quickly filter out potentially contagious people and rebuild a sense of safer workplaces, schools, airports and recreational gatherings.
Frequent ongoing screening in congregate settings reduces the risk of infection and
informs control measures.
Clinical data demonstrate that testing with the Panbio™ COVID-19 Ag Rapid Test Device can effectively identify both symptomatic and asymptomatic individuals who are contagious.
The Panbio™ COVID-19 Ag Rapid Test Device is accessible, affordable, easy to deploy, and provides quick, reliable results to help slow disease spread.
The Panbio™ COVID-19 Ag Rapid Test Device has demonstrated strong performance in suspected and symptomatic patients
Panbio™ COVID-19 Ag Rapid Test Device performance demonstrated a high positive agreement of 93.8% with PCR in asymptomatic patients with cycle threshold (Ct) values ≤ 30, which correlates with potential contagiousness.
The Ct value in RT-PCR refers to the number of cycles needed to amplify viral RNA
to reach a detectable level. Ct values are inversely related to viral burden; the lower the Ct, the more viral RNA is present, and the higher the Ct, the fewer copies of viral RNA are present in a sample.
A growing body of scientific literature on the correlation between contagiousness,
Ct counts and viral load suggests that at Ct counts in the 30s, the SARS-CoV-2 virus
no longer replicates, meaning people are no longer infectious.
For more product details, please click here for Panbio™ COVID-19 Ag Rapid Test Device Brochure
Specifications:
-
Brand: Abbott
-
Product: Panbio™ COVID-19 Ag Rapid Test Device Nasal (41FK11)
-
Contents:
25 Test Devices
1 Buffer (9 mL/bottle)
25 Extraction Tubes
25 Extraction Tube Caps
1 Positive Control Swab
1 Negative Control Swab
25 Sterilized Nasal Swabs for Sample Collection
1 Tube Rack
1 Quick Reference Guide
1 Instructions for Use
-
UOM: Box of 25 tests
- Image is sample of product